Assessment of the Safety and Therapeutic Benefits of Convalescent Plasma in COVID-19 Treatment: A Systematic Review and Meta-Analysis
Background: The coronavirus disease (COVID-19), caused by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), prompted a global health crisis, with no available specific treatments. Convalescent plasma (CP) with neutralizing antibodies could be a promising therapeutic approach to reduc...
Main Authors: | Daniela Ferreira Barreira, Rita Adubeiro Lourenço, Rita Calisto, Daniel Moreira-Gonçalves, Lúcio Lara Santos, Paula Alexandra Videira |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-04-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2021.660688/full |
Similar Items
-
Mortality Benefit of Convalescent Plasma in COVID-19: A Systematic Review and Meta-Analysis
by: Vikas Bansal, et al.
Published: (2021-04-01) -
Efficacy of convalescent plasma for the treatment of severe influenza
by: Zhiheng Xu, et al.
Published: (2020-07-01) -
The Effectiveness of Convalescent Plasma for the Treatment of Novel Corona Virus Disease 2019: A Systematic Review and Meta-Analysis
by: Huiling Cao, et al.
Published: (2021-09-01) -
Convalescent plasma: A potential therapeutic option for COVID-19 patients
by: Swee Li Ng, et al.
Published: (2020-01-01) -
Convalescent Plasma Therapy: An Effective Therapeutic Option to Treat COVID-19? A Narrative Review
by: Ray I, et al.
Published: (2020-10-01)